Hepatitis B virus (HBV) infection has been associated with a decreased prevalence of dyslipidaemia in cross-sectional studies, but cohort studies are limited. We investigated the longitudinal effects of chronic HBV infection on the development of dyslipidaemia. We performed a cohort study of 62 287 non-cirrhotic adult men and women free of dyslipidaemia who underwent serologic testing for hepatitis B surface antigen (HBsAg) and were followed annually or biennially for an average of 4.46 years. respectively. An inverse association between HBsAg positivity and incident high apolipoprotein B were also identified, with a corresponding a hazard ratio of 0.63 (0.55-0.72). In a large cohort of apparently healthy Korean adults, HBsAg seropositivity was associated with lower risk of development of dyslipidaemia, suggesting a role of HBV infection in lipid metabolism.
Summary
Hepatitis B virus (HBV) infection has been associated with a decreased prevalence of dyslipidaemia in cross-sectional studies, but cohort studies are limited. We investigated the longitudinal effects of chronic HBV infection on the development of dyslipidaemia. We performed a cohort study of 62 287 non-cirrhotic adult men and women free of dyslipidaemia who underwent serologic testing for hepatitis B surface antigen (HBsAg) and were followed annually or biennially for an average of 4.46 years.
A parametric proportional hazard model was used to estimate the adjusted hazard ratio with 95% confidence interval (CI) for incident dyslipidaemia according to HBsAg respectively. An inverse association between HBsAg positivity and incident high apolipoprotein B were also identified, with a corresponding a hazard ratio of 0.63 (0.55-0.72). In a large cohort of apparently healthy Korean adults, HBsAg seropositivity was associated with lower risk of development of dyslipidaemia, suggesting a role of HBV infection in lipid metabolism.
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| INTRODUC TI ON
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Furthermore, a meta-analysis of 14 cross-sectional studies reported an inverse relationship between HBsAg positivity and hypertriglyceridaemia. 9 However, the cross-sectional design of these studies limited their ability to establish a temporal relationship between HBV infection and reduced levels of lipid profiles. To the best of our knowledge, no previous longitudinal studies have evaluated the association between HBV infection and the development of dyslipidaemia among subjects free of dyslipidaemia at baseline. Therefore, using a large cohort compromising apparently healthy, non-diabetic and non-cirrhotic adults with normal baseline lipid profiles, we investigated the association between HBV infection and incidence of new-onset dyslipidaemia.
| MATERIAL AND ME THODS
| Study subjects
The Kangbuk Samsung Health Study is a longitudinal cohort study For additional analyses to examine the longitudinal association of HBsAg positivity with apolipoprotein A1 (apoA1) and apolipoprotein B (apoB), out of 40 331 subjects with available data for apoA1 and apoB (N = 40 331), subjects with low apoA1 levels and high apoB levels at baseline were excluded using the following criteria: 10 high apoB level ≥90 mg/dL (N = 557) and apoA1 level <120 mg/dL for men and <140 mg/dL for women (N = 1644). Accordingly, a total of 38 352 subjects were included in our final analysis.
was defined as a serum total cholesterol ≥200 mg/dL, high LDL cholesterolaemia consisting of LDL-C ≥ 100 mg/dL, hypertriglycer- Abdominal ultrasound scans were performed by experienced radiologists, all unaware of the study aims, using a 3.5-MHz probe.
Images were captured in a standard fashion with the patient in the supine position with the right arm raised above their head. An ultrasonographic diagnosis of fatty liver was determined based on standard criteria, including the presence of a diffuse increase in fine echoes in the liver parenchyma compared with the kidney or spleen parenchyma, deep beam attenuation and bright vessel walls. that the onset of dyslipidaemia had occurred at some point between the two visits, but did not know the precise timing, we used a parametric proportional hazard model to account for interval censoring (stpm command in Stata). 14 In these models, the baseline hazard function was parameterized with restricted cubic splines in log time with four degrees of freedom. We estimated the adjusted hazard ratio (aHR) with 95% confidence interval (CI) for incident dyslipidaemia. Statistical models were initially adjusted for age and sex and then for BMI, year of screening exam, smoking status, alcohol intake, regular exercise and education level. We assessed the proportional hazards assumption by examining graphs of estimated log (−log) survival.
For hypertriglyceridaemia, we performed stratified analyses in pre-specified subgroups defined by age (<40 vs ≥40 years), sex (men vs women), smoking (current smoker vs noncurrent smoker), alcohol intake (<20 g/day vs ≥20 g/day), vigorous exercise (<3 times/ week vs ≥3 times/week), BMI (<25 kg/m 2 vs ≥25 kg/m 2 ), HOMA-IR (<2.5 vs ≥2.5), ALT levels (<36 U/L vs ≥36 U/L) and fatty liver (No vs Yes). Interactions with subgroup characteristics were assessed using likelihood ratio tests comparing models with and without multiplicative interaction terms. All statistical analyses were performed using STATA version 14.0 (StataCorp LP, College Station, TX, USA).
All P-values were two-tailed, and P-values < 0.05 were considered statistically significant.
| RE SULTS
| Baseline characteristics of the study population
At baseline, 2511 (4.03%) of 62 287 participants were positive for HBsAg ( vs ≥3 times/week), BMI (<25 kg/m 2 vs ≥25 kg/m 2 ), HOMA-IR (< 2.5 vs ≥2.5), ALT levels (<36 U/L vs ≥36 U/L) or fatty liver (no vs yes) (Table 4) . Decreased risk for incident hypertriglyceridaemia was observed even in subjects without fatty liver or those without elevated ALT, indicating that the association between HBV infection and hypertriglyceridaemia is not fully explained by accompanying liver conditions. During the follow-up period, we also identified subjects with incident LC (N = 58) as well as subjects who started a new medication for hepatitis (N = 185) or dyslipidaemia (N = 306).
After excluding those cases, HBsAg positivity remained significantly associated with a lower incidence of hypercholesterolaemia, high LDL cholesterolaemia, hypertriglyceridaemia and high non-HDL cholesterolaemia (Appendix Table A1 ). On follow-up, 763 participants developed diabetes. After exclusion of additional incident diabetes, HBV infection was still significantly associated with decreased risk of incident dyslipidaemia (data not shown)
| D ISCUSS I ON
In this large cohort compromising 62 287 healthy adults with normal baseline lipid levels, HBsAg positivity was significantly associated with a lower incidence of dyslipidaemia including hypercholesterolaemia, high LDL cholesterolaemia, high non-HDL cholesterolaemia, hypertriglyceridaemia and high apoB. On the other hand, HBsAg positivity was associated with a higher incidence of low apoA levels. The incidence of low HDL cholesterolaemia tended to be higher in HBsAg-positive participants, compared to HBsAg-negative participants, but this association did not reach a statistical significance. Our findings suggest that HBV infection may interfere with lipid metabolism, resulting in lowering various lipid parameters.
The inverse association of HBsAg positivity with all lipid profiles including total cholesterol, TG, LDL-C and HDL-C has been reported in several cross-sectional studies. [5] [6] [7] [8] In a large community-based study compromising 56 336 Taiwan residents, HBsAg-positive subjects had a significantly lower prevalence of hypercholesterolaemia and hypertriglyceridaemia. 6 Likewise, in a study of 7695 health examinees, HBV infection was associated with lower levels of cholesterol, TG and LDL-C. 7 An analysis using the National Health weight to obese HBV-infected subjects. 23 Previous studies have indicated that adiponectin lowers serum TG levels by increasing very low-density lipoprotein-TG catabolism in skeletal muscle. 24, 25 However, further studies are needed to elucidate the mechanism underlying the inverse association between HBV infection and lipid profile changes.
We note that our study had several limitations. First, the associa- In addition to the large sample size, our study has several strengths including its prospective design; use of standardized clinical, imaging and laboratory procedures; and stringent quality control for data acquisition. The availability of detailed information on various covariates and all lipid profiles including apoA1 and apoB was another strength of this study that allowed us to perform a detailed analysis of each lipid parameter over time while adjusting for potential confounders. Furthermore, our study findings were derived from a relatively young and healthy population, and are thus less likely to be affected by confounding by comorbidities and medications associated with older populations.
In conclusion, in a cohort study of non-cirrhotic and non-diabetic adults, we demonstrated that HBsAg positivity was associated with decreased risk of hypercholesterolaemia, high LDL cholesterolaemia, high non-HDL cholesterolaemia, hypertriglyceridaemia and high apoB, but increased risk of low apoA, indicating that HBV has a lowering effect on lipid profiles. Understanding the mechanisms of HBV-associated changes in metabolic pathways may be useful for identifying potential targets for therapeutic intervention in HBV disease. 
ACK N OWLED G EM ENTS
CO N FLI C T S O F I NTE R E S T
The authors have no conflicts of interest to disclose.
AUTH O R CO NTR I B UTI O N S
Ryu S and Chang Y planned, designed, and directed the study, including quality assurance and control. Ryu S analysed the data and 
